Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays

Vaccine

Volumn 30, Issue 44, 2012, Pages 6327-6337

  Huang, Jhang Wei ^a   Lin, Wei Fan ^a   Yang, Jinn Moon ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Antigenic drift; Antigenic site; H1N1 virus; Hemagglutinin; Influenza vaccine

Indexed keywords

EPITOPE; HEMAGGLUTININ; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ARTICLE; HEMAGGLUTINATION INHIBITION; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; PANDEMIC INFLUENZA; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS STRAIN;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENIC VARIATION; COMPUTER SIMULATION; EPITOPES; EVOLUTION, MOLECULAR; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MUTATION, MISSENSE;

EID: 84865766554     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.079     Document Type: Article

References (40)

1. Johnson N.P., Mueller J. Updating the accounts: global mortality of the 1918-1920 Spanish influenza pandemic. Bull Hist Med 2002, 76(1):105-115.
2. Kawaoka Y., Krauss S., Webster R.G. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989, 63(11):4603-4608.
3. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992, 56(1):152-179.
4. Atassi M.Z., Smith J.A. A proposal for the nomenclature of antigenic sites in peptides and proteins. Immunochemistry 1978, 15(8):609-610.
5. Wiley D.C., Wilson I.A., Skehel J.J. Structural Identification of the antibody-binding sites of Hong-Kong influenza hemagglutinin and their involvement in antigenic variation. Nature 1981, 289(5796):373-378.
6. Wiley D.C., Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza-virus. Annu Rev Biochem 1987, 56:365-394.
7. Wilson I.A., Cox N.J. Structural basis of Immune recognition of influenza-virus hemagglutinin. Annu Rev Immunol 1990, 8:737-771.
8. Ndifon W., Wingreen N.S., Levin S.A. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc Natl Acad Sci USA 2009, 106(21):8701-8706.
9. Bush R.M., Fitch W.M., Bender C.A., Cox N.J. Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 1999, 16(11):1457-1465.
10. Plotkin J.B., Dushoff J., Levin S.A. Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci USA 2002, 99(9):6263-6268.
11. Bush R.M., Bender C.A., Subbarao K., Cox N.J., Fitch W.M. Predicting the evolution of human influenza A. Science 1999, 286(5446):1921-1925.
12. Deem M.W., Pan K.Y. The epitope regions of H1-subtype influenza A, with application to vaccine efficacy. Protein Eng Des Sel 2009, 22(9):543-546.
13. Pan K., Deem M.W. Quantifying selection and diversity in viruses by entropy methods, with application to the haemagglutinin of H3N2 influenza. J R Soc Interface 2011, 8(64):1644-1653.
14. Huang J.W., King C.C., Yang J.M. Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics 2009, 10(Suppl. 1):S41.
15. Huang J.W., Yang J.M. Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses. BMC Bioinformatics 2011, 12.
16. Plotkin J.B., Dushoff J. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci USA 2003, 100(12):7152-7157.
17. Li J., Wang Y., Liang Y., Ni B., Wan Y., Liao Z., et al. Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface display. Eur J Immunol 2009, 39(12):3498-3510.
18. Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W. The antigenic structure of the influenza-virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982, 31(2):417-427.
19. Brownlee G.G., Fodor E. The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 2001, 356(1416):1871-1876.
20. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305(5682):371-376.
21. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008, 26. pp. D31-D4.
22. Bao Y.M., Bolotov P., Dernovoy D., Kiryutin B., Zaslavsky L., Tatusova T., et al. The influenza virus resource at the national center for biotechnology information. J Virol 2008, 82(2):596-601.
23. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004, 32(5):1792-1797.
24. Webster R, Cox NJ, Stohr K. WHO manual on animal influenza diagnosis and surveillance. WHO/CDS/CSR/NCS/20025 2002;Rev.1.
25. Dujardin B., Vandenende J., Vangompel A., Unger J.P., Vanderstuyft P. Likelihood ratios - a real improvement for clinical decision-making. Eur J Epidemiol 1994, 10(1):29-36.
26. Grimes D.A., Schulz K.F. Refining clinical diagnosis with likelihood ratios. Lancet 2005, 365(9469):1500-1505.
27. Jaccard J., Sheng D. A comparison of 6 methods for assessing the importance of perceived consequences in behavioral decisions - applications from attitude research. J Exp Soc Psychol 1984, 20(1):1-28.
28. Lawrence C.E., Altschul S.F., Boguski M.S., Liu J.S., Neuwald A.F., Wootton J.C. Detecting subtle sequence signals: a Gibbs sampling strategy for multiple alignment. Science 1993, 262:208-214.
29. Lee M.S., Chen J.S. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 2004, 10(8):1385-1390.
30. Winter G., Fields S., Brownlee G.G. Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype. Nature 1981, 292(5818):72-75.
31. Chutinimitkul S., Herfst S., Steel J., Lowen A.C., Ye J., van Riel D., et al. Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol 2010, 84(22):11802-11813.
32. Li W., Shi W., Qiao H., Ho S.Y., Luo A., Zhang Y., et al. Positive selection on hemagglutinin and neuraminidase genes of H1N1 influenza viruses. Virol J 2011, 8:183.
33. Cox N.J., Bender C.A. The molecular epidemiology of influenza viruses. Semin Virol 1995, 6:359-370.
34. Gamblin S.J., Haire L.F., Russell R.J., Stevens D.J., Xiao B., Ha Y., et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 2004, 303(5665):1838-1842.
35. Pan K., Subieta K.C., Deem M.W. A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains. Protein Eng Des Sel 2011, 24(3):291-299.
36. Ferguson N.M., Galvani A.P., Bush R.M. Ecological and immunological determinants of influenza evolution. Nature 2003, 422(6930):428-433.
37. Fanning L.J., Connor A.M., Wu G.E. Development of the immunoglobulin repertoire. Clin Immunol Immunopathol 1996, 79(1):1-14.
38. Barbey-Martin C., Gigant B., Bizebard T., Calder L.J., Wharton S.A., Skehel J.J., et al. An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 2002, 294(1):70-74.
39. Xu R., Ekiert D.C., Krause J.C., Hai R., Crowe J.E., Wilson I.A. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 2010, 328(5976):357-360.
40. Igarashi M., Ito K., Yoshida R., Tomabechi D., Kida H., Takada A. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS One 2010, 5(1):e8553.